These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2755524)

  • 1. [Kinetics in toxicity studies].
    Rauws AG
    Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1260-4. PubMed ID: 2755524
    [No Abstract]   [Full Text] [Related]  

  • 2. [Age-related aspects of pharmacokinetics (a review of the literature)].
    Bezverkhaia IS; Zapadniuk VI
    Farmakol Toksikol; 1980; 43(1):115-9. PubMed ID: 6991280
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions of a cobra neurotoxin and affinity labels of the acetylcholine receptor in the electroplax.
    Prives JM; Reiter MJ; Cowburn DA; Karlin A
    Mol Pharmacol; 1972 Nov; 8(6):786-9. PubMed ID: 4641006
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of the relation between pharmacokinetic processes and pharmacological effects in humans].
    Dorokhov VV; Kholodov LE
    Farmakol Toksikol; 1985; 48(5):119-25. PubMed ID: 3908140
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced detoxication due to distributive catalysis and toxic thresholds: a kinetic analysis.
    Cook DL; Atkins WM
    Biochemistry; 1997 Sep; 36(36):10801-6. PubMed ID: 9312268
    [No Abstract]   [Full Text] [Related]  

  • 6. An introduction to clinical pharmacokinetics.
    Pfeifer HJ; Greenblatt DJ
    Compr Ther; 1979 Mar; 5(3):33-7. PubMed ID: 445982
    [No Abstract]   [Full Text] [Related]  

  • 7. Vulnerability of desensitized or curare-treated acetylcholine receptors to irreversible blockade by cobra toxin.
    Lester HA
    Mol Pharmacol; 1972 Nov; 8(6):632-44. PubMed ID: 4641003
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical relevance of pharmacokinetic differences in benzodiazepines].
    Weiershausen U
    Fortschr Med; 1981 Jun; 99(23):919-24. PubMed ID: 6114912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Equivalency of drugs and the problem of biological availability].
    Hirtz J
    Rev Prat; 1973 Nov; 23(53):7-10. PubMed ID: 4802222
    [No Abstract]   [Full Text] [Related]  

  • 10. The general problem of drug bioavailability and its assessment in man.
    Smith RN
    Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
    [No Abstract]   [Full Text] [Related]  

  • 11. The formulation of aspirin.
    Martin BK
    Adv Pharm Sci; 1971; 3():107-71. PubMed ID: 4947388
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetic models].
    Dahl S
    Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
    [No Abstract]   [Full Text] [Related]  

  • 13. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutical studies of oral formulations containing propyphenazone.
    Shekerdjiiski R; Paskov V; Lambov N; Gencheva P; Rachev D; Titeva S; Minkov E
    Pharmazie; 1987 Mar; 42(3):184-6. PubMed ID: 3602076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problem of tolerance and biological availability in the treatment with cytostatics].
    Czownicki Z
    Pol Tyg Lek; 1980 Dec; 35(51):2015-8. PubMed ID: 7017633
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection by timing treatment according to bodily rhythms - an analogy to protection by scrubbing before surgery.
    Halberg F
    Chronobiologia; 1974 Sep; 1 Suppl 1():27-72. PubMed ID: 4377961
    [No Abstract]   [Full Text] [Related]  

  • 17. Theory of the mean absorption time, an adjunct to conventional bioavailability studies.
    Cutler DJ
    J Pharm Pharmacol; 1978 Aug; 30(8):476-8. PubMed ID: 28392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of acetylcholine receptors by cobra toxin: electrophysiological studies.
    Lester HA
    Mol Pharmacol; 1972 Nov; 8(6):623-31. PubMed ID: 4344997
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics of iron ions].
    Wichliński L; Wiezowska B; Krzyśko K
    Acta Pol Pharm; 1981; 38(2):243-8. PubMed ID: 7315469
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability assessment under quasi- and nonsteady-state conditions. I: theoretical considerations.
    Kwan KC; Bondi JV; Yeh KC
    J Pharm Sci; 1975 Oct; 64(10):1639-42. PubMed ID: 1185529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.